Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 489.25
(-4.81%)
INR 489.25
(-4.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.14 Billion INR | 1.27% |
| 2022 | 13.96 Billion INR | -2.02% |
| 2021 | 14.25 Billion INR | 39.63% |
| 2020 | 10.2 Billion INR | -3.99% |
| 2019 | 10.63 Billion INR | 6.35% |
| 2018 | 9.99 Billion INR | -5.06% |
| 2017 | 10.53 Billion INR | 31911263.64% |
| 2016 | 33 Thousand INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 12.01 Billion INR | 228.24% |
| 2024 Q1 | -9.36 Billion INR | -166.22% |
| 2023 FY | 14.14 Billion INR | 1.27% |
| 2023 Q4 | 14.14 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 14.09 Billion INR | 0.0% |
| 2022 Q4 | 13.96 Billion INR | 0.0% |
| 2022 FY | 13.96 Billion INR | -2.02% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 13.65 Billion INR | 0.0% |
| 2021 FY | 14.25 Billion INR | 39.63% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 13.88 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 14.25 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 10.2 Billion INR | -3.99% |
| 2020 Q4 | 10.2 Billion INR | 0.0% |
| 2020 Q2 | 10.57 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 10.63 Billion INR | 6.35% |
| 2019 Q4 | 10.63 Billion INR | 54.34% |
| 2019 Q3 | 6.88 Billion INR | -36.13% |
| 2019 Q2 | 10.78 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 9.99 Billion INR | -5.06% |
| 2018 Q2 | 10.85 Billion INR | 0.0% |
| 2018 Q4 | 9.99 Billion INR | 0.0% |
| 2017 Q4 | 10.53 Billion INR | 17.21% |
| 2017 FY | 10.53 Billion INR | 31911263.64% |
| 2017 Q3 | 8.98 Billion INR | 0.0% |
| 2016 FY | 33 Thousand INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bal Pharma Limited | 2.51 Billion INR | -463.212% |
| Achyut Healthcare Limited | 2.01 Million INR | -702522.951% |
| Alkem Laboratories Limited | 48.6 Billion INR | 70.901% |
| Divi's Laboratories Limited | 18.99 Billion INR | 25.52% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 78.277% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | -172.999% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -375.595% |
| Mankind Pharma Limited | 23.87 Billion INR | 40.758% |
| Medicamen Biotech Limited | 940.36 Million INR | -1404.072% |
| Medico Remedies Limited | 438.24 Million INR | -3127.38% |
| Megasoft Limited | 1.85 Billion INR | -663.233% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -452.233% |
| Piramal Pharma Limited | 74 Billion INR | 80.888% |
| Sequent Scientific Limited | 8.27 Billion INR | -70.938% |
| Sigachi Industries Limited | 2.53 Billion INR | -458.764% |
| Ajanta Pharma Limited | 10.71 Billion INR | -32.058% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 92.295% |
| Brooks Laboratories Limited | 248.6 Million INR | -5589.358% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | -71.425% |
| Themis Medicare Limited | 1.88 Billion INR | -649.336% |
| Unichem Laboratories Limited | 8.06 Billion INR | -75.28% |
| Hester Biosciences Limited | 3.59 Billion INR | -293.46% |
| Venus Remedies Limited | 1.39 Billion INR | -915.494% |
| Indoco Remedies Limited | 10.34 Billion INR | -36.757% |
| Ind-Swift Limited | 13.45 Billion INR | -5.135% |
| Aarti Drugs Limited | 11.5 Billion INR | -22.947% |
| Alpa Laboratories Limited | 307.12 Million INR | -4505.271% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -286.326% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 86.778% |
| Granules India Limited | 22.95 Billion INR | 38.383% |
| Gufic Biosciences Limited | 5.59 Billion INR | -152.576% |
| Hikal Limited | 12.99 Billion INR | -8.841% |
| RPG Life Sciences Limited | 1.38 Billion INR | -924.765% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -595.29% |
| Windlas Biotech Limited | 1.76 Billion INR | -702.394% |
| ZIM Laboratories Limited | 2.08 Billion INR | -579.741% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -517.779% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | -123.48% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 76.917% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 90.708% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -190.566% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -4797.455% |
| Ipca Laboratories Limited | 33.74 Billion INR | 58.084% |
| Lasa Supergenerics Limited | 541.92 Million INR | -2509.918% |
| Laurus Labs Limited | 42.71 Billion INR | 66.888% |
| NATCO Pharma Limited | 10.53 Billion INR | -34.294% |
| Nectar Lifesciences Limited | 11.21 Billion INR | -26.08% |
| Shilpa Medicare Limited | 12.93 Billion INR | -9.367% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 82.762% |
| Wanbury Limited | 3.15 Billion INR | -348.224% |
| Wockhardt Limited | 39.87 Billion INR | 64.525% |
| Strides Pharma Science Limited | 37.68 Billion INR | 62.464% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -570.687% |
| Suven Life Sciences Limited | 148.62 Million INR | -9416.69% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -1704.461% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 13.089% |
| Eris Lifesciences Limited | 38.26 Billion INR | 63.04% |
| Lupin Limited | 96.23 Billion INR | 85.303% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -263.323% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -1113.84% |
| Valiant Laboratories Limited | 1.05 Billion INR | -1236.516% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 80.299% |
| FDC Limited | 3.7 Billion INR | -281.316% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | -32.086% |
| Novartis India Limited | 1.8 Billion INR | -685.287% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -4666.074% |
| Neuland Laboratories Limited | 5.49 Billion INR | -157.227% |
| Morepen Laboratories Limited | 4.45 Billion INR | -217.141% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -2096.641% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -615.667% |